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Abstract
Background: Reusable nasal-spray devices are frequently used in otolaryngologic examinations,
and there is an increasing concern about the risk of cross-contamination from these devices. The
aim of our study was to determine, by means of microbiologic analysis, the safety of a positive-
displacement or pump-type atomizer after multiple uses.
Methods: A reusable nasal spray bottle, pump, and tips were used in the nasal physical examination
of 282 patients admitted to a tertiary otolaryngology clinic. The effectiveness of 2 different methods
of prophylaxis against microbiologic contamination (the use of protective punched caps or rinsing
the bottle tip with alcohol) was compared with that of a control procedure.
Results: Although there was no statistically significant difference in positive culture rates among
the types of nasal spray bottles tested, methicillin-resistant coagulase-negative staphylococci were
isolated in 4 of 198 cultures.
Conclusion: Given these findings, we concluded that additional precautions (such as the use of an
autoclave between sprays, disposable tips, or disposable devices) are warranted to avoid
interpatient cross-contamination from a reusable nasal spray device.
Background
Topical vasoconstrictive and anesthetic agents that exert a
decongestant and/or local anesthetic action on the
mucous membranes of the nasal and pharyngeal cavities
are routinely used in otolaryngologic practice. To improve
the ease of the nasal examination and to make the patient
more comfortable, such agents are administered before
anterior rhinoscopy, flexible fiber optic or rigid endos-
copy, or videolaryngoscopy is performed. Devices that
deliver topical vasoconstrictive and anesthetic agents usu-
ally convey the medication by either of 2 methods: the
Venturi principle or the positive-pressure principle. The
risk of contamination of the medication delivery systems
as well as the risk of atomizer-associated cross-infection
has been investigated, and various results have been
reported. Obviously, the administration of an aerosolized
agent via a single-use atomizer is a definitive (but costly)
solution to that problem. In this study, we assessed the
risk of the cross-contamination of multiple-use positive-
pressure type nasal sprays and discussed relevant findings
in the literature.
Methods
The study consisted of the microbiologic examination of
multiple-dose decongestant nasal spray bottles used to
administer an aerosolized agent before the anterior rhino-
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scopic or fiberoptic endoscopic examination of 282
patients admitted to the Baskent University Ear, Nose, and
Throat Clinic during March 2005. The Baskent University
Institutional Ethics Committee approved the study proto-
col (Ref No. KA05/07). Written informed consent was
obtained from all subjects.
The medication contained in the spray bottles was a com-
bination of 0.05% oxymetazoline hydrochloride (a vaso-
constrictive agent) and 0.01% benzalkonium chloride (a
preservative) (Iliadin; Merck Ltd, Istanbul, Turkey). The
spray bottles were used in 2 different ways. Cap-off bottles
(Figure 1) were rinsed with 70% ethyl alcohol solution
after each use; cap-on bottles (Figure 1) received a new
clean, cap (punched to provide a hole of sufficient size)
for each patient.
Each participating physician used 2 spray bottles (1 cap-
on bottle and 1 cap-off bottle) on several patients in his or
her examination room during the course of single-day
outpatient examinations. For each patient requiring nasal
decongestion, medication was delivered by a cap-on spray
bottle to 1 nostril. A cap-off spray bottle was used to
administer medication to the other nostril. During that
procedure, the nozzle of the spray bottle was inserted
loosely into the nostril, and the bottle was squeezed twice.
The patient was asked to "sniff in" to ensure even distribu-
tion of the medicated spray. To assess the risk of contam-
ination from the environment, a third and last spray
bottle (the unused cap-off control group) was left on the
examination table and was not used throughout the day.
At the end of the day, the spray bottles were sent to the
microbiology laboratory with the following classifica-
tions: cap-off bottles (group 1), cap-on bottles (group 2),
or unused cap-off controls (group 3). Each group con-
tained 22 spray bottles, which denoted 22 physician-
examination days. Each spray bottle in groups 1 and 2 was
used on a mean of 12 ± 2 patients.
The 3 parts of each spray bottle (the tip, the inner part of
the pump, and the fluid remaining in the container) (Fig-
ure 2) were applied for culture onto sheep blood, choco-
late, and eosin-methylene blue agar. The tip of the pump
was streaked onto the agar surfaces. The inside of the
pump was rinsed with 1 mL of sterile distilled water, after
which 0.01 mL of that fluid was inoculated onto agar sur-
faces to reveal intraluminal colonization. A sample of the
fluid that remained in the spray bottle was also cultured.
The culture plates were incubated for 48 hours. Colonies
seen on the agar surfaces were examined, and the bacterial
strains were identified by conventional laboratory meth-
ods; an additional colony-forming unit count was not per-
formed.
The chi-square test and the Fisher exact test were used for
statistical analyses. A P value of less than .05 was consid-
ered a statistically significant result. Statistical analyses
were performed with Epi Info v. 6.0 (Center for Disease
Control and Prevention & WHO, Atlanta, Ga, USA).
Results
Sprays in groups 1 and 2 were used in 282 patients (151
women and 131 men; mean age, 46.2 years; age range,
12–81 years). Each spray was used on an average of 12.8
patients. A total of 198 cultures were performed from 66
spray devices during the study.
Colonies seen on the agar surfaces were further studied,
and methicillin-resistant coagulase-negative staphylococ-
cal strains were isolated from all 4 cultures with a positive
result. All of the positive results were from samples that
had been taken from the tip of the bottles. No bacterial
growth was evident in cultures taken from the inner side
of the pump or from the fluid that remained in the bottle.
Results of the cultures are presented in the Table 1.
There was no statistically significant difference in the pos-
itive culture rates among the 3 groups (P > .05, x2 = 3.73).
In addition, there was no statistically significant difference
between groups 1 and 2 when the control group was
excluded (P > .05, x2 = 0.28).
A) A spray bottle with its cap off (group 1) Figure 1
A) A spray bottle with its cap off (group 1). B) A spray bottle 
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Discussion
There are several reports in the literature regarding the risk
of contamination of devices that are used to deliver local
anesthetics and vasoconstrictive agents to patients in
otolaryngology clinics. Atomizers that work via the Ven-
turi principle have been studied; however, the risk of con-
tamination of multiuse sprays that work by means of a
positive displacement mechanism has yet to be estab-
lished [1-10].
In the Venturi effect, the velocity of a gas increases as the
corridor through which it passes narrows. The total energy
Table 1: Results of culture from the tip, the inner part of the pump, and fluid remaining in the nasal-spray container
Type of Nasal-Spray Container (group) Positive Cultures (No.) Negative Cultures (No.) Total
1 (Cap-off) 3 63 66
2 (Cap-on) 1 65 66
3 (Control) 0 66 66
Total 4 194 198
Various parts of the spray bottle that were subjected to culture Figure 2
Various parts of the spray bottle that were subjected to culture. A) Tip of the pump. B) Inside of the pump. C) Inside of the 
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does not change in a closed system, and as the velocity
(and therefore the kinetic energy) of the gas increases, its
potential energy decreases. The potential energy of a gas is
the pressure it exerts; thus, the decrease in potential energy
results in a decrease in gas pressure. A Venturi atomizer
causes a negative air pressure and creates a vacuum that
results in the suction and flow of the fluid out of the med-
ication reservoir and into the medication delivery tube.
The fluid column sucked up by the Venturi effect collapses
back into the bottle after the airflow has ceased; this
results in a transient suction at the tip that can aspirate
material into the device. Positive-displacement atomizers
do not rely on the Venturi principle but instead use the
noncompressible properties of fluid to atomize medica-
tions. In positive-displacement atomizers, manually
applied kinetic energy is transmitted through a spring-
driven pump system to the fluid and causes an increase in
the pressure, thus increasing the potential energy of the
fluid in the reservoir. The increase in potential energy in
turn drives the fluid through the pump lumen and out of
the tip. With the aid of a 1-way valve system that prevents
the "sucking back" of the fluid and/or a specifically
designed air-filter system that prevents the buildup of neg-
ative pressure in the bottle, the fluid does not flow back
into the bottle. This design theoretically lowers the risk of
contamination.
In 1993, Coakley and colleagues reported that nasal
sprays that operate via the Venturi principle have the dis-
advantage of sucking back, which makes them unhygienic
for use in more than 1 patient [1]. In a test of that type of
atomizer, those authors used a dye that was sucked back
into the lumen of the internal nozzle and contaminated
the fluid that remained in the reservoir. They concluded
that atomizers that work on the Venturi principle must be
replaced by disposable atomizers. Wolfe and coworkers
used high external concentrations of Staphylococcus aureus
in solution to investigate the internal contamination of
Venturi-principle atomizers and positive-displacement
atomizers [2]. They reported that external bacterial con-
tamination of the atomizer nozzle tip resulted in the inter-
nal bacterial contamination of the Venturi devices after a
single use, but that was not the case in positive displace-
ment devices.
In their study of Venturi atomizers in 12 healthy volun-
teers, Spraggs and colleagues [3] cultured samples from
different parts of the devices and compared the bacterial
colonies grown with the colonies from a previously col-
lected nasal swab. The culture results showed the trans-
mission of bacteria from the nasal vestibule onto the
nozzle tip, into the nozzle, and into the reservoir of the
atomizer and that the preservatives in the medication
administered exerted little antibacterial effect.
Southwick and colleagues investigated the association of
the transmission of tuberculosis via atomizer reuse and
concluded that contaminated atomizers may indeed cause
tuberculosis transmission [4]. In contrast, Visosky and
colleagues were unable to demonstrate the significant bac-
terial colonization of multiple-use atomizers in their out-
patient otolaryngology clinic [5]. The authors studied
serial dilutions of multidose-drug solutions in the atom-
izers to minimize the inhibitory effect of antiseptic agents
in drug formulations and reported that only 0.6% of the
drug solutions yielded bacterial growth (coagulase-nega-
tive Staphylococcus). They concluded that when aerosoliz-
ing equipment did not directly contact the patient and the
agents that were used contained a bacteriostatic preserva-
tive, using multiple-use atomizers did not pose the risk of
bacterial transmission among patients. In a study of Ven-
turi-type atomizers containing either lidocaine or tetrahy-
drozoline hydrochloride (Tyzine) that was applied with
the aid of a nasal speculum to reduce contact with the skin
and mucosa, Dubin and colleagues [10] showed that wip-
ing the nozzle of the atomizers with an isopropyl alcohol
pad after each use resulted in a significant reduction of
contamination (from 66% to 6%) in the lidocaine-con-
taining atomizers after 2 weeks, but that after 1 month, no
significant difference in the contamination rate between
the wiped and nonwiped atomizers was noted. Those
authors concluded that although a low level of contami-
nation of multiuse Venturi atomizers might occur in prac-
tice, it is of questionable clinical significance and that
wiping the tips of the devices with isopropyl alcohol
between uses could eliminate microbial growth for a 2-
week interval [10]. Similarly, Scianna and colleagues
advocate using an appropriate application technique; they
stated that continued use of the Venturi-system atomizer
is an acceptable practice [6].
In our study, 4 (2.02%) of the 198 cultures taken yielded
bacterial growth. In all of the positive cultures, methicil-
lin-resistant coagulase-negative staphylococci were recov-
ered from the tips of the sprayers. The lumen of the pump
and the solution that remained in the pump were not con-
taminated.
Bossart and Wolfe reviewed alternative topical medication
applicators that can safely deliver topical medications
without the risk of cross-infection [7]. Those authors
stated that positive-displacement atomizers with disposa-
ble tips can deliver an exact dose of many medications in
an atomized spray. Several methods of delivering local
anesthetic solutions are preferred in different clinics.
Some clinicians use disposable-tip protectors that fit onto
the tips of aerosol equipment. The single-use caps that fit-
ted onto the tip of the sprays in group 2 were designed to
prevent direct contact with nasal membranes. In our
study, we did not necessarily use a nasal speculum toPublish with BioMed Central    and   every 
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spread the patients' nares; therefore, the tip of the sprays
without a cap came into contact with the patients' nasal
mucosa. The use of a disposable punched cap seemed to
be a practical way of preventing contamination with nasal
flora, but 1 of the 4 positive results was obtained from the
spray with that type of cap. Although there was no statis-
tically significant difference, there were more positive
results of bacterial contamination from sprays without a
cap.
Whether the number needed to treat or statistical princi-
ples should be used in the evaluation of results like those
in our study is a matter of controversy. We suggest that
neither of the devices in our study is acceptable.
Because the inner parts of the pump and solutions were
not contaminated, replacing the nozzle tip with a new
sterilized tip after each use or simply using disposable tips
for each patient may be a practical and inexpensive policy.
For example, the sterilization of 1 tip with ethylene oxide
currently costs about €0.005 at our hospital. However, the
safety of that alternative must to be proven in further stud-
ies. Furthermore, it is impossible to isolate some impor-
tant pathogens, such as Mycobacterium tuberculosis, viruses,
or prions, with conventional microbiologic culture meth-
ods (sheep blood, chocolate, and eosin-methylene blue
agars). Such pathogens can also easily contaminate the
devices and play a role in cross-infection.
Conclusion
Although no statistically significant difference was present
in the groups studied, bacterial growth was identified in 4
of the cultures. Therefore, the ideal method of eliminating
cross-infection at the time of this writing is to use a new
disposable nasal spray bottle for each patient. We suggest
that conducting further studies of this issue with larger
groups is necessary, and we concluded that every precau-
tion must be taken to minimize the risk of cross-infection
from nasal sprays.
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